Vyles, D., Gnagi, F., Bulloch, B., Muenzer, J., & Hu, C. (2016). Procalcitonin as a Marker of Bacteremia in Patients With Fever and Acute Lymphoblastic Leukemia. Pediatric emergency care, 32(9), 590-3.
Children undergoing treatment for acute lymphoblastic leukemia (ALL) often present to the emergency department (ED) with a fever. They are at high risk of bacteremia secondary to being immunocompromised. Recent reports indicate that procalcitonin (PCT) is a useful marker of bacteremia in children.
Yanez, N. D., Aljasser, I., Andre, M., Hu, C., Juraska, M., & Lumley, T. (2017). Assessing the impact of measurement error in modeling change in the absence of auxiliary data. COMMUNICATIONS IN STATISTICS-THEORY AND METHODS, 46(6), 2667-2680.
Chen, Z., Klimentidis, Y. C., Bea, J. W., Ernst, K. C., Hu, C., Jackson, R., & Thomson, C. A. (2017). Body Mass Index, Waist Circumference, and Mortality in a Large Multiethnic Postmenopausal Cohort-Results from the Women's Health Initiative. Journal of the American Geriatrics Society, 65(9), 1907-1915.
To determine whether the relationship between anthropometric measurements of obesity and mortality varies according to age, race, and ethnicity in older women.
Garvie, P. A., Flynn, P. M., Belzer, M., Britto, P., Hu, C., Graham, B., Neely, M., McSherry, G. D., Spector, S. A., Gaur, A. H., & , P. A. (2011). Psychological factors, beliefs about medication, and adherence of youth with human immunodeficiency virus in a multisite directly observed therapy pilot study. The Journal of adolescent health : official publication of the Society for Adolescent Medicine, 48(6), 637-40.
This study examined psychological functioning and beliefs about medicine in adolescents with human immunodeficiency virus (HIV) on highly active antiretroviral therapy in a community-based directly observed therapy (DOT) pilot feasibility study. Participants were youth with behaviorally acquired HIV (n = 20; 65% female; median age, 21 years) with adherence problems, who received once-daily DOT. Youth were assessed at baseline, week 12 (post-DOT), and week 24 (follow-up). At baseline, 55% of youth reported having clinical depressive symptoms compared to 27% at week 12 with sustained improvements at week 24. At baseline, substance use was reported within the borderline clinical range (T(score) = 68), with clinical but statistically nonsignificant improvement (T(score) = 61) at week 12. Hopelessness scores reflected optimism for the future. Coping strategies showed significantly decreased cognitive avoidance (p = .02), emotional discharge (p = .004), and acceptance/resignation ("nothing I can do," p = .004), whereas positive reappraisal and seeking support emerged. With the exception of depressive symptoms, week 12 improvements were not sustained at week 24. DOT adherence was predicted by higher baseline depression (p = .05), beliefs about medicine (p = .006) and perceived threat of illness scores (p = .03). Youth with behaviorally acquired HIV and adherence problems who participated in a community-based DOT intervention reported clinically improved depressive symptoms, and temporarily reduced substance use and negative coping strategies. Depressive symptoms, beliefs about medicine, and viewing HIV as a potential threat predicted better DOT adherence.
Burgess, J. L., Griffin, S., Jung, A. M., Hu, C., & Bui, D. P. (2018). Use of telematics data to identify driving behaviors associated with emergency service vehicle crashes. AAP.